Trademark Overview
On Tuesday, September 30, 2025, a trademark application was filed for SYNTASE with the United States Patent and Trademark Office. The USPTO has given the SYNTASE trademark a serial number of 99421485. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 30, 2025. This trademark is owned by CRISPR Therapeutics AG. The SYNTASE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy; Research in the field of gene editing technology; Providing a gene editing platform for others to conduct pharmaceutical research and development in the field of in vivo gene editing therapy
